首页> 外文期刊>Obstetrics and Gynecology: Journal of the American College of Obstetricians and Gynecologists >Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.
【24h】

Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.

机译:人类免疫缺陷病毒1型相关核酸和乳头瘤病毒DNA在免疫缺陷病毒感染妇女的宫颈阴道分泌物中。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To evaluate simultaneous human immunodeficiency virus (HIV)-related nucleic acids and human papillomavirus (HPV)-DNA in cervicovaginal secretions of HIV-seropositive women. METHODS: We collected 47 paired blood and cervicovaginal lavage samples from 124 known HIV-1-seropositive women. Proviral HIV-1 DNA, cell-associated, and cell-free HIV-1 RNA in cervicovaginal secretions were quantitatively evaluated by competitive polymerase chain reaction (PCR) and reverse transcription PCR. Polymerase chain reaction and subsequent restriction fragment length polymorphism analysis of PCR products were used to detect HPV types 6, 11, 16, 18, 31, 33, 35, and 56. RESULTS: Proviral HIV-1 DNA, cell-associated, and cell-free HIV-1 RNA were detected in 52.4% (65 of 124), 38.7% (48 of 124), and 33.9% (42 of 124) of lavage samples, respectively. Human papillomavirus-DNA in cervicovaginal secretions was detected in 64% (79 of 124) of participants. The rate of detection of HPV types of intermediate to high oncogenic risk was higher in HIV-positive women who tested positive for cell-associated (odds ratio [OR] 3.57, 95% confidence interval [CI] 1.17, 11.12) or cell-free (OR 4.63, 95% CI 1.42, 15.51) HIV-1 RNA in cervicovaginal secretions than their counterparts who tested negative. Logistic regression analysis showed that the association between HPV infection and the detection of HIV-1 RNA in cervicovaginal secretions persisted after adjustment for potential confounders such as CD4+ cell counts, HIV-1 RNA in plasma, use of antiretroviral drugs, vaginal infection, and regular condom use. In univariable and multivariable analysis, HPV-DNA detection was associated with amounts of cell-free and cell-associated HIV-1 RNA in cervicovaginal secretions (chi(2) for trend 10.35, and 9.84, P =.001 and.002, respectively). CONCLUSIONS: The rate of HPV detection in the genital tract of HIV-1-seropositive women is associated with the amount of cell-associated and cell-free HIV-1 RNA present in cervicovaginal secretions. The association does not appear to be attributable entirely to the effect of HIV-related immunodepression.
机译:目的:评估HIV血清反应阳性妇女宫颈阴道分泌物中同时存在的人类免疫缺陷病毒(HIV)相关核酸和人类乳头瘤病毒(HPV)-DNA。方法:我们从124名已知HIV-1血清阳性女性中收集了47对配对的血液和宫颈阴道灌洗液样本。通过竞争性聚合酶链反应(PCR)和逆转录PCR定量评估宫颈阴道分泌物中的原病毒HIV-1 DNA,细胞相关和无细胞HIV-1 RNA。聚合酶链反应和随后的PCR产物限制性片段长度多态性分析用于检测HPV类型6、11、16、18、31、33、35和56。结果:HIV-1 DNA原病毒,与细胞相关的细胞和细胞在灌洗样品中分别检出了52.4%(124个中的65个),38.7%(124个中的48个)和33.9%(124个中的42个)游离HIV-1 RNA。在64%(124名中的79名)参与者中检测到宫颈阴道分泌物中的人乳头瘤病毒-DNA。 HIV阳性女性中与细胞相关的检测为阳性(几率[OR] 3.57,95%置信区间[CI] 1.17,11.12)或无细胞,对HPV类型中度至高致癌风险的检出率更高。 (OR 4.63,95%CI 1.42,15.51)宫颈阴道分泌物中的HIV-1 RNA比测试阴性的同伴。 Logistic回归分析表明,在调整了可能的混杂因素(例如CD4 +细胞计数,血浆中的HIV-1 RNA,使用抗逆转录病毒药物,阴道感染和常规感染)后,HPV感染与宫颈阴道分泌物中HIV-1 RNA的检测之间的关联仍然存在。使用避孕套。在单变量和多变量分析中,HPV-DNA检测与宫颈阴道分泌物中无细胞和细胞相关的HIV-1 RNA的量相关(趋势10.35和9.84的chi(2),P = .001和.002,分别为)。结论:HIV-1血清阳性妇女生殖道中HPV的检出率与宫颈阴道分泌物中存在的细胞相关和无细胞HIV-1 RNA的量有关。这种关联似乎并不完全归因于与HIV相关的免疫抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号